Intermediates in the synthesis of purines and pteridines: N-methylated 6-chlorouracils
Kazimierczuk, Z.; Shugar, D.
Acta Biochimica Polonica 17(4): 325-329
1970
ISSN/ISBN: 0001-527X PMID: 5495361 Document Number: 24694
Document emailed within 1 workday
Related Documents
Kazimierczuk, Z.; Lipski, M.; Shugar, D. 1972: Intermediates in the synthesis of purines and pteridines: selective hydrolysis of chloropyrimidines Acta Biochimica Polonica 19(4): 359-366Vashishat, R.K.; Kaushal, B. 1983: Effect of colchicine & methylated purines on UV-induced mitotic gene conversion in Saccharomyces cerevisiae Indian Journal of Experimental Biology 21(7): 367-370
Gait, M.J.; Popov, S.G.; Singh, M.; Titmas, R.C. 1980: Rapid synthesis of oligodeoxyribonucleotides. V. Further studies in solid phase synthesis of oligodeoxyribonucleotides through phosphotriester intermediates Nucleic Acids Symposium Series 7: 243-257
Pawłowski, M.; Drabczyńska, A.; Gorczyca, M.; Malec, D.; Modzelewski, J. 1994: Synthesis and pharmacological screening of novel 10-substituted diazepino-[2,1-f]-purines Acta Poloniae Pharmaceutica 51(4-5): 385-391
Zheng, X.; Hu, X. 2006: Rapid analysis of two intermediates in caffeine synthesis by RP-HPLC Se Pu 24(2): 205
Strauss, D.; de Verdier, C.D. 1980: Preservation of red blood cells with purines and nucleosides. III. Synthesis of adenine, guanine, and hypoxanthine nucleotides Folia Haematologica 107(3): 434-453
Gajdos, A.; Gajdos-Török, M. 1972: Inhibitory effect of certain intermediates of anaerobic glycolysis on the synthesis of porphyrins by Rhodopseudomonas spheroides Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 166(6): 816-819
Dutler, H.; Bizzozero, S.A.; Benz, P.; Zbinden, P. 1991: Structure-activity correlation in serine-protease catalyzed peptide synthesis based on modeled intermediates Biomedica Biochimica Acta 50(10-11): S149-S154
Cieślak, J.; Sobkowski, M.; Jankowska, J.; Wenska, M.; Szymczak, M.; Imiolczyk, B.; Zagórowska, I.; Shugar, D.; Stawiński, J.; Kraszewski, A. 2001: Nucleoside phosphate analogues of biological interest, and their synthesis via aryl nucleoside H-phosphonates as intermediates Acta Biochimica Polonica 48(2): 429-442
Anjalika; Gupta, I.; Gupta, S.K.; Ganguly, N.K. 1999: Reactive oxygen intermediates and reactive nitrogen intermediates in copper intrauterine device users Contraception 59(1): 67-70
Strauss, D.; de Verdier, C.H. 1980: Preservation of red blood cells with purines and nucleosides. II. Uptake and utilization of purines and nucleosides by stored red blood cells Folia Haematologica 107(3): 417-433
Martin, J.H.; Edwards, S.W. 1993: Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing Journal of Immunology 150(8 Pt 1): 3478-3486
Dhondt, J.L.; Farriaux, J.P. 1980: Tetrahydroblopterin. Metabolism and metabolic role of unconjugated pteridines Pathologie-Biologie 28(6): 397-405
Platonenkova, L.S.; Kiseleva, O.A.; Kondrat'eva, E.N. 1972: Formation of non-conjugated pteridines by phototrophic bacteria in relation to growth conditions Mikrobiologiia 41(5): 818-822
Zeitler, H.J.; Andondonskaja-Renz, B. 1986: Separation of pteridines from blood cells and plasma by reverse-phase high-performance liquid chromatography Methods in Enzymology 122: 273-293
Sopin, E.F.; Tsudzevich, B.A. 1973: Methylated ATP derivatives Ukrains'kyi Biokhimichnyi Zhurnal 45(5): 602-604
Al-Shamiri, S.A.; Hasan, N.A.; Frankul, W.M.; Al-Hamdi, A.T. 2009: Purines and oxypurines in myocardial ischemia Saudi Medical Journal 30(2): 257-266
Webster, H.K. 1984: Role of purines in lymphocyte function Asian Pacific Journal of Allergy and Immunology 2(2): 311-317
Kohda, K.; Itano, K.; Kobayasi, I.; Ohta, M.; Asano, S.; Kawazoe, Y. 1991: Syntheses and properties of N-aminated purines and pyrimidines Nucleic Acids Symposium Series 25: 3-4
Liu, X.J.; Salter, M.W. 2005: Purines and pain mechanisms: recent developments Current Opinion in Investigational Drugs 6(1): 65-75